Taimei Baofa Cancer Hospital

Taimei Baofa Cancer Hospital is a specialized oncology facility located in Dongping, China, founded by Dr. Yu Baofa. The hospital is known for its proprietary UMIPIC (Ultra-minimum Incision Personalized Intratumoral Chemo-immunotherapy) technology, which involves the direct injection of customized drug combinations into solid tumors. This approach aims to maximize local drug concentration while minimizing systemic toxicity, effectively turning the tumor into an in-situ vaccine. The hospital provides comprehensive cancer care, focusing on late-stage and complex cases across various solid tumor types. Its clinical model integrates traditional oncology with innovative drug delivery systems to improve patient outcomes and quality of life.